tiprankstipranks
Percheron Therapeutics (PERCF)
OTHER OTC:PERCF
US Market
PERCF
Percheron Therapeutics
RESEARCH TOOLSreports
Want to see PERCF full AI Analyst Report?

Percheron Therapeutics (PERCF) Income Statement

13 Followers

Percheron Therapeutics Income Statement

Last quarter (Q2 2026), Percheron Therapeutics's total revenue was AU$0.00, a decrease of ― from the same quarter last year. In Q2, Percheron Therapeutics's net income was AU$-3.11M. See Percheron Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Gross Profit
AU$ -67.98KAU$ -79.42KAU$ -95.20KAU$ -89.22KAU$ -103.32K
Operating Expenses
AU$ 16.64MAU$ 14.80MAU$ 13.25MAU$ 7.52MAU$ 8.58M
Depreciation and Amortization
AU$ 67.98KAU$ 79.42KAU$ 95.20KAU$ 89.22KAU$ 103.32K
EBITDA
AU$ -16.27MAU$ -11.84MAU$ -13.25MAU$ -7.52MAU$ -8.58M
Operating Income
AU$ -16.71MAU$ -14.88MAU$ -13.34MAU$ -7.61MAU$ -8.68M
Other Income/Expenses
AU$ 356.16KAU$ 608.89KAU$ 385.30KAU$ 21.52KAU$ 44.88K
Pretax Income
AU$ -16.35MAU$ -14.27MAU$ -12.96MAU$ -7.59MAU$ -8.64M
Net Income
AU$ -14.92MAU$ -11.92MAU$ -11.38MAU$ -5.81MAU$ -8.06M
Per Share Metrics
Basic EPS
AU$ -0.01AU$ -0.02AU$ -0.02AU$ -0.01AU$ -0.01
Diluted EPS
AU$ -0.01AU$ -0.02AU$ -0.02AU$ -0.01AU$ -0.01
Weighted Average Shares Outstanding
 1.02B 669.03M 669.03M 634.29M 540.98M
Weighted Average Shares Outstanding (Diluted)
 1.02B 669.03M 669.03M 634.29M 540.98M
Currency in AUD

Percheron Therapeutics Earnings and Revenue History